Many factors affect the risk of post-operative HCC recurrence, including tumor size, tumor encapsulation, microvascular invasion, liver cirrhosis, serum α-fetoprotein (AFP) level >400 μg/L and use of antiviral drugs [11–14]. This evidence concerns the gene AFP and neoplasm.